Vault-13

NEWAMSTERDAM PHARMA COMPANY NAMSW

*W EXP 11/22/202 · Equity WRT · CUSIP N62509117

9 institutional holders +0 vs Q1 2026
1,309,1941.3m shares reported held*
$28.1mreported value*
0 new 2 added 0 reduced 0 sold out net bought ≈ $274.5k (+12.8k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $21.46. Options: 1 managers hold calls ($1.6m notional), 0 hold puts (—).

Trends to Q2 2026

Institutional holders

Managers reporting a position, each quarter

0102030Q4 22: 23Q1 23: 20Q2 23: 20Q3 23: 20Q4 23: 19Q1 24: 12Q2 24: 11Q3 24: 12Q4 24: 12Q1 25: 11Q2 25: 11Q3 25: 9Q4 25: 9Q1 26: 9Q2 26: 99Q4 22Q4 23Q4 24Q4 25Q2 26
Numbers
QuarterHolders
Q4 202223
Q1 202320
Q2 202320
Q3 202320
Q4 202319
Q1 202412
Q2 202411
Q3 202412
Q4 202412
Q1 202511
Q2 202511
Q3 20259
Q4 20259
Q1 20269
Q2 20269

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
404Q3 24: 2 bought or addedQ3 24: 2 cut or sold outQ4 24: 3 bought or addedQ4 24: 3 cut or sold outQ4 24Q1 25: 1 bought or addedQ1 25: 3 cut or sold outQ2 25: 2 bought or addedQ2 25: 2 cut or sold outQ2 25Q3 25: 0 bought or addedQ3 25: 3 cut or sold outQ4 25: 1 bought or addedQ4 25: 4 cut or sold outQ4 25Q1 26: 1 bought or addedQ1 26: 1 cut or sold outQ2 26: 2 bought or addedQ2 26: 0 cut or sold outQ2 26
Numbers
QuarterBought or addedCut or sold out
Q3 202422
Q4 202433
Q1 202513
Q2 202522
Q3 202503
Q4 202514
Q1 202611
Q2 202620

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$500k$1m$1.5m$2mQ3 25 calls: $1.3mQ3 25 puts: $0Q3 25P/C 0.00Q4 25 calls: $1.7mQ4 25 puts: $0Q4 25P/C 0.00Q1 26 calls: $1.5mQ1 26 puts: $0Q1 26P/C 0.00Q2 26 calls: $1.6mQ2 26 puts: $0Q2 26P/C 0.00
Numbers
QuarterCallsPutsP/C
Q3 2025$1.3m$00.00
Q4 2025$1.7m$00.00
Q1 2026$1.5m$00.00
Q2 2026$1.6m$00.00

Biggest buyers

WOLVERINE ASSET MANAGEMENT LLC Added +12,798+12.8k
UBS Group AG Added +47+47

Biggest sellers

None

Biggest calls

MILLENNIUM MANAGEMENT LLC Unchanged $1.6m75.0k shares

Biggest puts

None

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Insider purchases and sales since 1 Apr 2026

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
505Q4 24: 0 buyingQ4 24: 1 sellingQ1 25: 1 buyingQ1 25: 4 sellingQ1 25Q2 25: 1 buyingQ2 25: 1 sellingQ3 25: 1 buyingQ3 25: 3 sellingQ3 25Q4 25: 0 buyingQ4 25: 1 sellingQ1 26: 0 buyingQ1 26: 5 sellingQ1 26Q2 26: 0 buyingQ2 26: 1 sellingQ3 26: 1 buyingQ3 26: 3 sellingQ3 26
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q4 20240—1$707.4k—
Q1 20251$109.7k4$3.1m—
Q2 20251$236.8k1$1.9m$1.9m
Q3 20251$58.4k3$9.1m$2.1m
Q4 20250—1$5.2m$5.2m
Q1 20260—5$46.7m$28.1m
Q2 20260—1$3.5m$3.5m
Q3 20261$226.5k3$6.6m$6.5m
DateInsiderTradeSharesPrice ValueTheir holding
2026-09-14 Davidson Michael H. Chief Executive Officer, director Bought 10,000 $22.65 $226.5k10.0k shares +1%
2026-09-04 Smither John W Director Sold 1,600 $25.32 $40.5k1.6k shares -15%
2026-08-24 Kastelein Johannes Jacob Pieter Chief Scientific Officer, director · See footnotes Sold plan 125,000 $26.91 $3.4m125.0k shares -64%
2026-07-20 Kooij Louise Frederika Chief Accounting Officer Sold plan 105,000 $30.34 $3.2m105.0k shares -81%
2026-06-22 Kooij Louise Frederika Chief Accounting Officer Sold plan 40,000 $30.20 $1.2m40.0k shares -62%
2026-05-26 Kooij Louise Frederika Chief Accounting Officer Sold plan 65,000 $35.69 $2.3m65.0k shares -73%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q2 2026

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Frazier Life Sciences Management, L.P. 0.23% of their portfolio PALO ALTO, CA 500,333500.3k $10.7m $10.7m 0.23% Unchanged
2 RA CAPITAL MANAGEMENT, L.P. 0.06% of their portfolio BOSTON, MA 333,333333.3k $7.1m $7.1m 0.06% Unchanged
3 Affinity Asset Advisors, LLC 0.26% of their portfolio NEW YORK, NY 245,000245.0k $5.3m $5.3m 0.26% Unchanged
4 Bain Capital Life Sciences Investors, LLC 0.13% of their portfolio Boston, MA 99,999100.0k $2.1m $2.1m 0.13% Unchanged
5 DEERFIELD MANAGEMENT COMPANY, L.P. 0.02% of their portfolio New York, NY 92,78792.8k $2.0m $2.0m 0.02% Unchanged
6 ARISTEIA CAPITAL, L.L.C. 0.01% of their portfolio GREENWICH, CT 15,70815.7k $343.4k $343.4k 0.01% Unchanged
7 WOLVERINE ASSET MANAGEMENT LLC 0.00% of their portfolio CHICAGO, IL 14,92514.9k $318.9k $318.9k 0.00% Added +12.8k +12,798
8 Vestcor Inc 0.00% of their portfolio FREDERICTON, A3 6,6666.7k $143.0k $143.0k 0.00% Unchanged
9 UBS Group AG 0.00% of their portfolio ZURICH, V8 443443 $8.5k $8.5k 0.00% Added +47 +47